Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Type of study
Language
Publication year range
1.
Toxicology ; 242(1-3): 16-22, 2007 Dec 05.
Article in English | MEDLINE | ID: mdl-17976885

ABSTRACT

Recently, H(2)S (an environmental toxin) was proposed to induce cytotoxicity not only by inhibiting cytochrome oxidase but also by generating reactive oxygen species [Truong, D., Eghbal, M., Hindmarsh, W., Roth, Sh., O'Brien, P., 2006. Molecular mechanisms of hydrogen sulfide toxicity. Drug Metab. Rev. 38, 733-744]. In the following, evidence is presented supporting the use of hydroxocobalamin (vitamin B(12a)) as an antidote against H(2)S poisoning. More than 60% of the mice administered 35 mg/kg (0.63 mmol/kg) of NaSH (LD(90)) survived (at 24 h) when hydroxocobalamin (0.25 mmol/kg) was given after NaSH administration whereas less than 15% of the mice survived without hydroxocobalamin. Hydroxocobalamin (50-100 microM) or cobalt (50-100 microM) also prevented hepatocyte cytotoxicity induced by NaSH (500 microM). Furthermore, adding hydroxocobalamin 60 min later than NaSH still showed some protective activity. Catalytic amounts of hydroxocobalamin or cobalt added to a solution containing NaSH caused the disappearance of NaSH and induced oxygen uptake, indicative of NaSH oxidation and Co reduction, respectively.


Subject(s)
Antidotes/pharmacology , Cobalt/pharmacology , Environmental Pollutants/toxicity , Hepatocytes/drug effects , Hydrogen Sulfide/toxicity , Hydroxocobalamin/pharmacology , Sulfides/toxicity , Vitamin B Complex/pharmacology , Animals , Antidotes/therapeutic use , Catalase/metabolism , Cell Survival/drug effects , Cell-Free System/drug effects , Cell-Free System/metabolism , Cobalt/therapeutic use , Dose-Response Relationship, Drug , Environmental Pollutants/metabolism , Hydrogen Sulfide/metabolism , Hydroxocobalamin/therapeutic use , In Vitro Techniques , Lethal Dose 50 , Male , Mice , Oxidation-Reduction , Oxygen/metabolism , Poisoning/etiology , Poisoning/prevention & control , Rats , Rats, Sprague-Dawley , Reactive Oxygen Species/metabolism , Sulfides/metabolism , Time Factors , Vitamin B Complex/therapeutic use
3.
Drug Metab Rev ; 38(4): 733-44, 2006.
Article in English | MEDLINE | ID: mdl-17145698

ABSTRACT

RATIONALE: The toxicity of H2S has been attributed to its ability to inhibit cytochrome c oxidase in a similar manner to HCN. However, the successful use of methemoglobin for the treatment of HCN poisoning was not successful for H2S poisonings even though the ferric heme group of methemoglobin scavenges H2S. Thus, we speculated that other mechanisms contribute to H2S induced cytotoxicity. Experimental procedure. Hepatocyte isolation and viability and enzyme activities were measured as described by Moldeus et al. (1978), and Steen et al. (2001). RESULTS: Incubation of isolated hepatocytes with NaHS solutions (a H2S source) resulted in glutathione (GSH) depletion. Moreover, GSH depletion was also observed in TRIS-HCl buffer (pH 6.0) treated with NaHS. Several ferric chelators (desferoxamime and DETAPAC) and antioxidant enzymes (superoxide dismutase [SOD] and catalase) prevented cell-free and hepatocyte GSH depletion. GSH-depleted hepatocytes were very susceptible to NaHS cytotoxicity, indicating that GSH detoxified NaHS or H2S in cells. Cytotoxicity was also partly prevented by desferoxamine and DETAPC, but it was increased by ferric EDTA or EDTA. Cell-free oxygen consumption experiments in TRIS-HCl buffer showed that NaHS autoxidation formed hydrogen peroxide and was prevented by DETAPC but increased by EDTA. We hypothesize that H2S can reduce intracellular bound ferric iron to form unbound ferrous iron, which activates iron. Additionally, H2S can increase the hepatocyte formation of reactive oxygen species (ROS) (known to occur with electron transport chain). H2S cytotoxicity therefore also involves a reactive sulfur species, which depletes GSH and activates oxygen to form ROS.


Subject(s)
Air Pollutants/toxicity , Hydrogen Sulfide/toxicity , Animals , Cell Survival/drug effects , Cell-Free System , Edetic Acid/pharmacology , Ferric Compounds/metabolism , Ferrous Compounds/metabolism , Glutathione/metabolism , Hepatocytes/drug effects , Hepatocytes/metabolism , In Vitro Techniques , Iron Chelating Agents/pharmacology , Male , Oxidation-Reduction , Oxygen Consumption/drug effects , Rats , Rats, Sprague-Dawley , Reactive Oxygen Species/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...